How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,398 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood

Criteria Inclusion Criteria: Able to read and understand English Male or female, 35-70 years old (inclusive) Total Fasting Plasma Cholesterol of 200 to 240 mg/dl Willing to maintain American heart Association (AHA) Step 1 diet for the duration of the study. Agree to abstain from consuming large amounts of grapefruit juice for the duration of the study. Exclusion Criteria: Any subject with an National Cholesterol Education Program (NCEP) 10-year cardiovascular (CV) risk > 10% will be excluded. Women who (...) Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2014 Clinical Trials

182. Triglyceride/High-density Lipoprotein Cholesterol Ratio in Chronic Kidney Disease

Study to Investigate the Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio To Predict Cardiovascular Outcomes in Chronic Kidney Disease. Study Start Date : January 2009 Actual Primary Completion Date : January 2013 Actual Study Completion Date : January 2013 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : All cause mortality [ Time Frame: 30 months ] The COX analysis (...) Triglyceride/High-density Lipoprotein Cholesterol Ratio in Chronic Kidney Disease Triglyceride/High-density Lipoprotein Cholesterol Ratio in Chronic Kidney Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2014 Clinical Trials

183. Replacement of Saturated Fat in Dairy on Total Cholesterol

) Taking vitamin, mineral or fatty acid supplements (e.g. fish oil, calcium) Pregnant, lactating, planning a pregnancy or not using effective contraceptive precautions Smokers Vegans Anaemic Planning or on a weight reduction scheme Parallel participation in another intervention study Participating in intensive aerobic activity for > 20 minutes 3 times per week Use of anti-inflammatory medication Contacts and Locations Go to Information from the National Library of Medicine To learn more about (...) : July 24, 2017 Last Verified: May 2016 Keywords provided by Julie Lovegrove, University of Reading: Milk fatty acids Total cholesterol Vascular function Blood pressure Additional relevant MeSH terms: Layout table for MeSH terms Hypercholesterolemia Hyperlipidemias Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases

2014 Clinical Trials

184. Serum Cholesterol and Gastric Neoplasm

2018 Estimated Study Completion Date : June 2019 Resource links provided by the National Library of Medicine related topics: resources: Groups and Cohorts Go to Group/Cohort Intervention/treatment Gastric cancer No intervention Other: No intervention No intervention will be needed. Outcome Measures Go to Primary Outcome Measures : Cholesterol level in paitents with and withoutgastric neoplasm [ Time Frame: up to 24 months ] Serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG (...) subjects who visited the department of gastroenterology, surgery, or Healthcare Screening & Promotion Center at Asan Medical Center and diagnosed as gastric cancer Exclusion Criteria: Subjects who has history about drug for cholesterol, diabetes, liver disease, and/or thyroid disease. Subjects who do not want to be enrolled this study Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff

2014 Clinical Trials

185. Dose of Labeled Cholesterol for Kinetics: A Pilot Study

: Dose of Labeled Cholesterol and Phenylalanine for HDL Kinetics: A Pilot Study Study Start Date : February 2014 Actual Primary Completion Date : November 2015 Actual Study Completion Date : December 2015 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Tracer Other: stable isotope of cholesterol Outcome Measures Go to Primary Outcome Measures : Incorporation of orally administered 13C3 cholesterol (...) Dose of Labeled Cholesterol for Kinetics: A Pilot Study Dose of Labeled Cholesterol for Kinetics: A Pilot Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Dose of Labeled Cholesterol for Kinetics

2014 Clinical Trials

186. The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome

The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02065180 Recruitment Status : Completed First

2014 Clinical Trials

187. Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

within four (4) weeks of randomization. Medications excluded within 4 weeks of randomization are: prescription omega-3 fatty acids, statins, bile acid sequestrants, cholesterol absorption inhibitors, niacin or fibrates. Dietary supplements excluded within 4 weeks prior to randomization are: L-carnitine, policosanol, guggulipid, sterol/stanol products, red rice yeast supplements, garlic supplements, soy isoflavone supplements, niacin or its analogues, probiotics and dietary fiber supplements (...) of the trial) Exclusion Criteria: Individuals with intolerance of, or allergy to red yeast rice or omega 3 fatty acids. Individuals currently taking a statin (HMG-CoA Reductase inhibitor) including Lipitor, Zocor, Crestor, Pravachol, Lescol, Livalo) or other lipid metabolism altering product within four (4) weeks prior to randomization who do not wish to withdraw from therapy. Individual taking prescription or over the counter medications (including dietary supplements) known to alter lipid metabolism

2014 Clinical Trials

188. Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment

: Interventional (Clinical Trial) Actual Enrollment : 150 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Screening Official Title: Phase 4 Study of Effect of Testosteron Treatment on the Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism Study Start Date : July 2013 Actual Primary Completion Date : April 2014 Actual Study Completion Date : April 2014 Resource links provided (...) to change of TG/HDL cholesterol ratio with testosteron replacement [ Time Frame: baseline and 6 months ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table

2014 Clinical Trials

189. Effect of Dietary Fibre on Serum Cholesterol Levels

. For example, results from new research are now challenging the previously approved health claims for soy foods and fatty acids. This is a major public health concern because if clinical evidence is not reliable, it could lead to harm. Since the publication of the meta-analysis by Brown et. al (1999) over a decade ago, scientists have continued to research the effects of soluble fiber on cholesterol levels with new technology and trial designs, therefore it is crucial to revisit the question and update (...) : Soluble Fibre Study Design Go to Layout table for study information Study Type : Observational Estimated Enrollment : 1000 participants Time Perspective: Retrospective Official Title: Effect of Viscous Soluble Fibers on Serum Cholesterol Levels: A Series of Systematic Reviews and Meta-analyses Study Start Date : January 2014 Estimated Primary Completion Date : January 2017 Estimated Study Completion Date : January 2017 Resource links provided by the National Library of Medicine related topics: Groups

2014 Clinical Trials

190. Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol

Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study Study Start Date : October 2014 Actual Primary Completion Date : October 2015 Actual Study Completion Date : October 2015 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment (...) test at study entry for females of child bearing potential. Females of child bearing potential practicing reliable contraception throughout the study period (not including oral contraceptives). Hypertensive patients must be well controlled by stable dose of anti-hypertensive medication for at least 2 months prior to screening (and the stable dose can be maintained throughout the study). Patients treated with vitamin E(>400IU/die), or Polyunsaturated fatty acid (>2g/d) or Ursodeoxycholic acid

2014 Clinical Trials

191. The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients

HbA1c 7.0-10.0% Exclusion Criteria: Acute illness or infection Recent (within 1 month) surgery, trauma, cardiovascular event Recent (within 3 months) variation of statin therapy/dose Therapy with HDL-modifying drugs, such as fibrates, omega-3 fatty acids, and niacin Alcoholism Very high baseline HDL levels (>90 mg/dL) Previous history of recurrent (≥2 episodes) urinary tract infections or genital infections (a single remote episode not to be considered an exclusion criterion) History of hypotension (...) The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2014 Clinical Trials

192. Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis

-hydroxycholesterol, 27-hydroxycholesterol and 7α-hydroxycholestenone) were measured by High Performance Liquid Chromatography tandem Mass Spectrometry in these subjects throughout along the study in order to demonstrate the effect of different red meat on the hepatic metabolism of cholesterol. Condition or disease Intervention/treatment Phase Lipid Metabolism Disorders Sterols Diet, High-Fat Cholesterol Fatty Acids Hyperlipidemias Behavioral: Changes in cholesterol metabolism Other: Lean red meat diet Other: Fat (...) parameters are determined: anthropometric (weight, waist, circumference and body mass index), blood pressure, dietary (72-hours dietary registry) and exercise assessments and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoprotein A1, apolipoprotein B, iron, transferring, ferritin, uric acid, glucose, HbA1c and insulin). Serum concentration of non cholesterol sterols (sitosterol, campesterol, stigmasterol, desmosterol and lanosterol) and oxysterols (24S

2014 Clinical Trials

193. The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study

Trial) Actual Enrollment : 0 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Triple (Participant, Care Provider, Investigator) Primary Purpose: Supportive Care Official Title: The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study Study Start Date : October 2014 Actual Primary Completion Date : February 2016 Actual Study Completion Date : February 2016 Resource links provided by the National Library of Medicine related topics: Arms (...) Lipoprotein Cholesterol [ Time Frame: 3 months ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years

2014 Clinical Trials

194. A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

of Subcutaneously Administered ALN PCSSC in Subjects With Elevated Low Density Lipoprotein Cholesterol Study Start Date : December 2014 Actual Primary Completion Date : May 2015 Actual Study Completion Date : November 2015 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: ALN-PCSSC Drug: ALN-PCSSC Single or multiple doses of ALN-PCSSC by subcutaneous (sc) injection Placebo Comparator: Sterile Normal Saline (0.9 (...) A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C) A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2014 Clinical Trials

195. Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester

to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 119 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Triple (Participant, Care Provider, Investigator) Primary Purpose: Treatment Official Title: Serum Cholesterol Reduction Efficacy of Biscuit With Added Plant Stanol Ester Study Start Date : March 2013 Actual Primary Completion Date : August 2013 Actual Study Completion Date : August 2013 Resource links provided (...) Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Serum

2014 Clinical Trials

196. Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

] Change in fatty acid fraction [ Time Frame: 52-weeks ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 20 (...) Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2014 Clinical Trials

197. Cholesterol-lowering Effects of Plant Stanol Ester

Cholesterol-lowering Effects of Plant Stanol Ester Cholesterol-lowering Effects of Plant Stanol Ester - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Cholesterol-lowering Effects of Plant Stanol Ester (...) Go to Brief Summary: Efficacy of plant stanols as esters on LDL-cholesterol reduction is well documented. LDL-cholesterol lowering efficacy of the ingredient administered in a smoothie is less well known. Condition or disease Intervention/treatment Phase Dyslipidemias Hypercholesterolemia Hyperlipidemias Dietary Supplement: Plant stanol ester Dietary Supplement: placebo Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual

2014 Clinical Trials

198. Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia

PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia Study Start Date : January 2014 Actual Primary Completion Date : April 2014 Actual Study Completion Date : April 2014 Resource links provided by the National Library of Medicine related topics: related topics: Groups and Cohorts Go to Group/Cohort Controls Familial hypercholesterolemia Outcome Measures Go to Primary Outcome Measures : Impact of PCSK9 on LDL-C concentrations [ Time Frame: Week 1 (...) Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You

2014 Clinical Trials

199. Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood

regression models will be used to evaluate the change in LDL cholesterol over time between the 3 groups Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table (...) Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2014 Clinical Trials

200. High-intensity Aerobic Interval Training in Testicular Cancer Survivors

High-intensity Aerobic Interval Training in Testicular Cancer Survivors High-Intensity Aerobic Interval Training in Testicular Cancer Survivors - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. High-Intensity (...) Aerobic Interval Training in Testicular Cancer Survivors (HIITTS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02459132 Recruitment Status : Completed First Posted : June 1, 2015 Last Update Posted : April 21, 2017 Sponsor: University of Alberta Information provided by (Responsible Party

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>